Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination

Completed

• Conditions: Anus Neoplasms

• Registration Number: NCT00799474
• Lead Sponsor: University of North Carolina, Chapel Hill

Brief Summary

This research focuses on men who have sex with men (MSM) who are at higher risk of anal cancer. The survey will evaluate their beliefs about anal and oral cancer, their knowledge about role of human papillomavirus (HPV) infection in these cancers, and their knowledge of HPV vaccination and anal Pap smears. Approximately 12% of subjects will be HIV-positive.

Detailed Description

Little research has examined men's understanding of what causes anal and oral cancers and whether HPV vaccination can play a potential protective role. This research focuses on men who have sex with men (MSM) who are at notably elevated risk of anal cancer, and seeks to characterize their beliefs about anal and oral cancer, knowledge about the etiological role of HPV infection in these cancers, as well as their knowledge of HPV vaccination and anal Pap smears. We will also study heterosexual men.

Study Timeline

• Study First Submitted: 2008-11-26
• Study First Submitted QC: 2008-11-26
• Study First Posted: 2008-11-27
• Study Start: 2008-12
• Primary Completion: 2009-01
• Study Completion: 2009-01
• Results First Submitted: 2009-12-07
• Results First Submitted QC: 2009-12-07
• Status Verified: 2010-01
• Results First Posted: 2010-01-15
• Last Update Submitted: 2016-02-25
• Last Update Posted: 2016-03-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 609

Inclusion Criteria

• male
• aged 18-59
• answered question about sexual orientation

Read More

Exclusion Criteria

• none

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Willingness to Receive the Human Papillomavirus (HPV) Vaccine	at time of interview	Measured participants' willingness to receive HPV vaccine. Participants were asked how willing they would be to get HPV vaccine if it were approved for use in males. A 5-point scale ranging from "definitely not willing" to "definitely willing" was used to meausure willingness.

Secondary Outcome Measures

Name	Time	Method
Awareness of HPV Vaccine	At time of interview	Measured if participants had heard of HPV vaccine prior to survey. Participants were asked if they had heard to HPV vaccine prior to the survey and had response options of "yes", "no", and "I don't know".
Knowledge of HPV	At time of interview	Assessed participants' knowledge of HPV by summing correct responses to nine HPV knowledge items. Questions addressed what diseases are associated with HPV, how HPV is transmitted, and how common HPV infection is. For each item, participants were classified as having answered the item correctly or incorrectly.